Fate therapeutics to host virtual event at the 2021 ash annual meeting

San diego, dec. 08, 2021 (globe newswire) -- fate therapeutics, inc. (nasdaq: fate), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, today announced that management will host a virtual event entitled “b -cell lymphoma franchise update” on tuesday, december 14, 2021 at 8:00 am et.

FATE Ratings Summary

FATE Quant Ranking